Compugen(CGEN) - 2025 Q1 - Earnings Call Transcript

Compugen (CGEN) Q1 2025 Earnings Call May 19, 2025 08:30 AM ET Company Participants Yvonne Naughton - VP, Head of Investor Relations & Corporate CommunicationsAnat Cohen-Dayag - CEO, President & DirectorDavid Silberman - Chief Financial OfficerMichelle Mahler - Chief Medical OfficerEran Ophir - Chief Scientific OfficerRohan Mathur - Biopharma Equity Research Associate Conference Call Participants Daina Graybosch - Senior Managing Director, Biotechnology AnalystAsthika Goonewardene - Analyst Operator Ladies ...